IRADIMED CORP (IRMD)

↓ Download CSV

CIK 0001325618 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, IRADIMED CORP reported revenue of $83.81M, up 14.4% from the prior year. The company was profitable, with a net margin of 26.8% and a gross margin of 76.7%. It held $108.78M in total assets against $14.16M in total liabilities.

Key ratios (FY2025)

76.7%
Gross margin
31.2%
Operating margin
26.8%
Net margin
23.8%
Return on equity
+14.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$83.81M$73.24M$65.56M$53.30M$41.81M$31.72M$38.52M$30.44M$23.08M$32.50M
Cost of Revenue$19.49M$16.89M$15.40M$12.02M$9.76M$8.14M$8.82M$7.21M$5.57M$6.15M
Gross Profit$64.32M$56.35M$50.16M$41.28M$32.05M$23.57M$29.70M$23.23M$17.51M$26.34M
Operating Income$26.15M$21.96M$20.04M$15.63M$9.82M-$756.1K$8.65M$6.00M$1.29M$10.92M
Net Income$22.48M$19.23M$17.19M$12.83M$9.33M$1.37M$9.63M$6.30M$499.8K$7.21M
EPS (Diluted)$1.75$1.50$1.35$1.02$0.74$0.11$0.78$0.52$0.04$0.60
Total Assets$108.78M$98.33M$92.16M$85.51M$82.88M$71.07M$66.73M$48.44M$39.01M$37.19M
Total Liabilities$14.16M$11.51M$20.74M$11.84M$10.71M$9.68M$11.20M$6.50M$6.08M$5.31M
Shareholders' Equity$94.62M$86.82M$71.42M$73.67M$72.17M$61.38M$55.52M$41.95M$32.93M$31.89M
Cash & Equivalents$51.16M$52.23M$49.76M$57.96M$62.00M$50.07M$43.48M$28.03M$18.21M$17.71M
Operating Cash Flow$24.95M$25.62M$13.47M$10.04M$11.26M$5.82M$10.23M$7.38M$3.42M$9.41M
Capital Expenditures$7.76M$8.01M$7.44M$823.0K$482.3K$443.0K$368.3K$228.3K$775.6K$780.8K
Shares Outstanding12.78M12.71M12.66M12.59M12.54M12.31M11.77M10.99M10.60M10.72M
Dividends Per Share$0.48